Back to TSHA

MPM BioImpact LLC → TSHA

MPM BioImpact LLC TSHA Position History

Taysha Gene Therapies, Inc. • Healthcare

Quarters held
2
Latest value
$35.4M
Q3 2026
Peak value
$35.4M
First seen
Q2 2026

Dollar value over time

Show data table
PeriodPosition value
Q2 2026$30.6M
Q3 2026$35.4M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$35.4M7.26M——
Q2 2026$30.6M4.50M——

Other funds holding TSHA

Other MPM BioImpact LLC positions

CGEM

Cullinan Therapeutics, Inc.

$177.2M
AKTS

Aktis Oncology, Inc.

$155.9M
CGEM

Cullinan Therapeutics, Inc.

$149.2M
LQDA

Liquidia Corporation

$110.5M
DBVTF

DBV Technologies S A

$108.9M
CGEM

Cullinan Therapeutics, Inc.

$108.7M
AKTS

Aktis Oncology, Inc.

$94.2M
RVMDW

Revolution Medicines, Inc.

$92.2M